arrow
J

Juan V. Apala

hospital universitario 12 de octubre
H指数:5
被引数:182

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Phosphoproteomic analysis of neoadjuvant breast cancer suggests that increased sensitivity to paclitaxel is driven by CDK4 and filamin A
2022-12-0711
OAAI
Immuno-priming durvalumab with bevacizumab in HER2-negative advanced breast cancer: a pilot clinical trial

免疫引发durvalumab联合贝伐单抗治疗HER2-negative晚期乳腺癌的临床试验

2020-11-1122
OAAI
Nintedanib plus letrozole in early breast cancer: a phase 0/I pharmacodynamic, pharmacokinetic, and safety clinical trial of combined FGFR1 and aromatase inhibition

尼达尼布联合来曲唑治疗早期乳腺癌: FGFR1和芳香化酶联合抑制的0/I期药效学、药代动力学和安全性临床试验

2019-05-2418
OAAI
In vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer
2018-08-2943
OAAI